Share on StockTwits

Eagle Pharmaceuticals (NASDAQ:EGRX) released its earnings data on Monday. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.16, AR Network reports. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $3.40 million.

Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) opened at 10.35 on Monday. Eagle Pharmaceuticals has a 52 week low of $9.16 and a 52 week high of $16.44. The stock has a 50-day moving average of $12.73 and a 200-day moving average of $12.25. The company’s market cap is $145.1 million.

Eagle Pharmaceuticals, Inc (NASDAQ:EGRX) is a specialty pharmaceutical company.

Receive News & Ratings for Eagle Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.